Drug
Part A
Part A: highest development phase Phase 1, developed by Junshi Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Junshi Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Part A NCT03474640 | Phase 1 | Advanced Malignancies |
Latest
No recent events.
Follow Part A on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.